Lorrey, S., Wachsmuth, L., Finlay, J., Neff, C., Ayasoufi, K., Waibl Polania, J., … Fecci, P. (2023). Glioblastoma and other intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses. bioRxiv. https://doi.org/10.1101/2023.11.02.565368

Lorrey, Selena, Lucas Wachsmuth, John Finlay, Corey Neff, Katayoun Ayasoufi, Jessica Waibl Polania, Alexandra Hoyt-Miggelbrink, et al. “Glioblastoma and other intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses.” BioRxiv, 2023. https://doi.org/10.1101/2023.11.02.565368.

Lorrey S, Wachsmuth L, Finlay J, Neff C, Ayasoufi K, Waibl Polania J, et al. Glioblastoma and other intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses. bioRxiv. 2023.

Lorrey, Selena, et al. “Glioblastoma and other intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses.” BioRxiv, 2023. Epmc, doi:10.1101/2023.11.02.565368.

Lorrey S, Wachsmuth L, Finlay J, Neff C, Ayasoufi K, Waibl Polania J, Hoyt-Miggelbrink A, Price M, Rein L, Dell S, Reesman R, Cui X, Hawley A, Lerner E, Wilkinson D, Srinivasan E, Walsh K, Patel A, Ostrom Q, Fecci P. Glioblastoma and other intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses. bioRxiv. 2023.